Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/1995
06/15/1995CA2176825A1 C5a receptor antagonists having substantially no agonist activity
06/15/1995CA2175701A1 Bicyclic heterocycles as neurokinin a antagonists
06/15/1995CA2155202A1 Bicyclic carboxylic acid leukotriene b4 antagonists
06/15/1995CA2137976A1 Thienothiazine derivatives
06/14/1995EP0657469A1 L-Selectin cleavage site, methods of diagnosis and usage thereof
06/14/1995EP0657468A1 Human stromae derived factor
06/14/1995EP0657459A1 Thienothiazine derivates, process for their preparation and their use as anti-inflammatory and analgesic agents
06/14/1995EP0657458A1 Protein kinase C inhibitors
06/14/1995EP0657451A2 Pyrrolidine derivatives inhibitors of leukotriene biosynthesis
06/14/1995EP0657443A1 Optically active carboxamide derivative
06/14/1995EP0657164A1 Pharmaceutical compositions containing staurosphorine derivatives
06/14/1995EP0656944A1 Human melanocyte stimulating hormone receptor
06/14/1995EP0656906A1 A novel endothelial cell molecule mediating lymphocyte binding in man
06/14/1995EP0656904A1 Peptide inhibitors of selectin binding
06/14/1995EP0525111B1 Antiinflammatory hydroxamic acids and n-hydroxyureas
06/14/1995EP0494260B1 Granulocyte-colony stimulating factor receptors
06/14/1995CN1028863C 3-cycloalkyl-prop-2-enamide derivatives
06/13/1995US5424425 Analgesics, antidepressants, hypotensive agent and treats irritable bowel syndrome and congestive heart failure
06/13/1995CA1335892C Saccharide derivatives
06/08/1995WO1995015384A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition
06/08/1995WO1995015339A1 Antagonists to chaperonin 10
06/08/1995WO1995015338A1 Chaperonin 10
06/08/1995WO1995015318A1 1,3,5-trisubstituted pyrazole compounds for treatment of inflammation
06/08/1995WO1995015317A1 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders
06/08/1995WO1995015316A1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
06/08/1995WO1995015315A1 1,5-diphenyl pyrazole compounds for treatment of inflammation
06/08/1995WO1995015311A1 Tachykinin antagonists
06/08/1995WO1995015179A1 Method of treating intestinal disorders
06/08/1995WO1995015169A1 Use of dimeticone for treating aphthae and stomatitis
06/08/1995WO1995013071A3 Treatment of immunoregulatory disorders
06/08/1995CA2177994A1 Tachykinin antagonists
06/08/1995CA2177824A1 1,5-diphenyl pyrazole compounds for treatment of inflammation
06/08/1995CA2177699A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition
06/08/1995CA2177574A1 1,3,5-trisubstituted pyrazole compounds for treatment of inflammation
06/08/1995CA2177573A1 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders
06/08/1995CA2177570A1 Method of treating intestinal disorders
06/07/1995EP0656354A1 Substituted N-piperidino 3-pyrazolecarboxamide
06/07/1995EP0656213A1 Treatment of conditions and disease
06/07/1995EP0656207A1 Non-chlorofluorocarbon aerosol formulations
06/07/1995EP0656206A1 Non-chlorofluorocarbon aerosol formulations
06/07/1995EP0656115A1 Improved detection and therapy of lesions with biotin/avidin conjugates
06/07/1995EP0656061A1 Novel glycoforms of soluble complement receptor 1
06/07/1995EP0656015A1 New nimesulide salt cyclodextrin inclusion complexes
06/07/1995EP0656008A1 Thrombin receptor antagonists
06/07/1995EP0655996A1 Substituted benzylamino nitrogen containing non-aromatic heterocycles
06/07/1995CN1103533A Biologically active ureido derivatives useful as antimetastatic agents
06/07/1995CN1103402A Substituted pyrroles
06/07/1995CN1028757C Process for preparing heterocyclic derivatives
06/07/1995CA2137443A1 Thienothiazinderivatives, process for their preparation and their use
06/06/1995US5422424 Antibiotic cryptdin peptides and methods of their use
06/06/1995US5422359 α-aminoketone derivatives
06/06/1995US5422354 Quinuclidine derivatives
06/06/1995US5422102 Diclofenac or salt with nonionic polymer of hydroxypropyl and/or hydroxyethyl cellulose; percutaneous adsorption
06/06/1995CA1335816C 4-pyridyl-1,3-dioxan-5-ylalkenoic acid derivatives
06/06/1995CA1335800C Synovial phospholipases
06/06/1995CA1335792C Method and dosage form using an antagonist to gamma interferon to control mhc-associated autoimmune disease
06/06/1995CA1335789C Fatty acid compositions
06/01/1995WO1995014697A1 Heterocyclic esters of rapamycin and pharmaceutical compositions containing them
06/01/1995WO1995014696A1 Hindered esters of rapamycin and their use as pharmaceuticals
06/01/1995WO1995014687A1 Novel substituted thiosemicarbazonic acid esters
06/01/1995WO1995014686A1 Novel substitued thiosemicarbazonethiones
06/01/1995WO1995014685A1 Novel substituted thiosemicarbazone derivatives
06/01/1995WO1995014683A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
06/01/1995WO1995014681A1 Isoxazoline compounds as antiinflammatory agents
06/01/1995WO1995014680A1 3-aryl-2-isoxazolines as antiinflammatory agents
06/01/1995WO1995014670A1 Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action
06/01/1995WO1995014669A1 Novel benzenesulfonylimine derivatives as inhibitors of il-1 action
06/01/1995WO1995014667A1 Substituted indoles as phosphodiesterase type iv inhibitors
06/01/1995WO1995014477A1 The use of an ester of inositoltrisphosphate for the treatment of inflammatory conditions
06/01/1995WO1995014464A1 Ssi tyrphostins and pharmaceutical compositions
06/01/1995CA2224051A1 Intermediates for producing substituted indoles as phosphodiesterase type iv inhibitors
06/01/1995CA2224049A1 Intermediates for producing substituted indoles as phosphodiesterase type iv inhibitors
06/01/1995CA2177375A1 3-aryl-2-isoxazolines as antiinflammatory agents
06/01/1995CA2177289A1 Ssi tyrphostins and pharmaceutical compositions
06/01/1995CA2176961A1 Heterocyclic esters of rapamycin and pharmaceutical compositions containing them
06/01/1995CA2176955A1 Hindered esters of rapamycin and their use as pharmaceuticals
06/01/1995CA2174838A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
06/01/1995CA2153690A1 Novel substituted thiosemicarbazonic acid esters
06/01/1995CA2153689A1 Novel substituted thiosemicarbazone derivatives
06/01/1995CA2153580A1 Novel substitued thiosemicarbazonethiones
05/1995
05/31/1995EP0655462A1 Linear adhesion inhibitors
05/31/1995EP0655460A1 Pharmacotherapeutical use of glutathione derivatives
05/31/1995EP0655442A1 Piperazine derivatives as Tachykinin antagonists
05/31/1995EP0655055A1 Tachykinin antagonists
05/31/1995EP0654994A1 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
05/31/1995EP0576420B1 Novel derivative of caffeic acid, oraposide, cosmetic or pharmaceutical, particularly dermatological, composition containing it
05/31/1995CN1028639C Improvements in and relating to leukotriene antagonists
05/30/1995US5420298 Pyrrolidine derivatives
05/30/1995US5420297 Peptides having substance P antagonistic activity
05/30/1995US5420296 Angiogenesis inhibitors and cardiovascular disorders
05/30/1995US5420287 1,2 diarylcyclopentenyl compounds for the treatment of inflammation
05/30/1995US5420273 Condensed heterocyclic compounds
05/30/1995US5420243 Transforming growth factor
05/30/1995US5420131 Platelet activating factor antagonist or 5-lipoxygenase inhibitors
05/30/1995US5420109 Cytokine restraining agents
05/30/1995US5419915 Medicament with an analgesic, antipyretic and/or antiphlogistic action and use of 2-ethoxybenzoic acid
05/30/1995CA2136712A1 Piperazine derivatives
05/26/1995WO1995014095A1 Endothelin-converting enzyme
05/26/1995WO1995014017A1 Non-peptide tachykinin receptor antagonists
05/26/1995WO1995014007A1 Phenyl-alkyl imidazoles as h3-receptor antagonists
1 ... 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 ... 1272